MedTrace Logo

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

NCT02279264 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-10-31

No results posted yet for this study

Summary

Objectives:

1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor
2. To determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG tube prior to feedings
3. To establish normative pH values for neonates

Conditions

  • Establish Normative pH Values in Neonates

Interventions

DEVICE

RightSpot Infant pH Indicator

pH indicator

Sponsors & Collaborators

  • RightBio Metrics

    lead INDUSTRY

Eligibility

Min Age
24 Weeks
Max Age
40 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02279264 on ClinicalTrials.gov